8-K
filed May 14, 2024, 7:59 PM ET
ticker ATRC
CIK 0001323885
other material
confidence high
sentiment neutral
materiality 0.30
AtriCure shareholders approve increase in authorized shares under 2023 Stock Incentive Plan to 2.8M
AtriCure, Inc.
- Shareholders approved amendment to 2023 Stock Incentive Plan, increasing shares from 1,000,000 to 2,800,000.
- Shareholders approved amendment to certificate of incorporation to limit officer liability under Delaware law.
- Nine director nominees elected; Deloitte ratified as auditor; say-on-pay approved with 35.6M for vs 6.5M against.
Key facts
Extracted from this filing and checked against the source text.
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
AtriCure, Inc.: Amendment to Second Amended and Restated Certificate of Incorporation to limit liability of certain officers (effective 2024-05-13).
- Change
- charter amendment
- Effective
- 2024-05-13
Exact text from the filing
At the Annual Meeting, the stockholders of the Company approved an amendment (the “Amendment”) to the Company’s Second Amended and Restated Certificate of Incorporation to limit the liability of certain officers of the Company as permitted by the Delaware General Corporation Law. The Amendment became effective immediately upon the filing of a certificate of amendment setting forth the same with the Secretary of State of the State of Delaware on May 13, 2024.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
AtriCure, Inc. shareholders approved Ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024 at the 2024-05-14 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2024-05-14
Exact text from the filing
2. The stockholders approved the proposal to ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024. For: 44,157,266 Against: 550,817 Abstain: 82,226
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
AtriCure, Inc. shareholders approved Approval of an amendment to the Company’s Second Amended and Restated Certificate of Incorporation to limit the liability of certain officers of the Company at the 2024-05-14 meeting.
- Proposal
- charter amendment
- Outcome
- passed
- Meeting
- 2024-05-14
Exact text from the filing
5. The stockholders approved the amendment to the Company’s Second Amended and Restated Certificate of Incorporation to limit the liability of certain officers of the Company. For: 37,737,714 Against: 4,398,481 Abstain: 78,142 Broker Non-Votes: 2,575,972
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
AtriCure, Inc. shareholders approved Election of Regina E. Groves as director at the 2024-05-14 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2024-05-14
Exact text from the filing
Each nominee for director was duty elected to serve one-year terms expiring at the 2025 Annual Meeting of Stockholders and until their successors have been duly elected and qualified. Director Nominees For Against Abstain Broker Non-Votes Michael H. Carrel 41,522,276 637,966 54,095 2,575,972 Regina E. Groves 41,564,382 594,967 54,988 2,575,972 B. Kristine Johnson 40,322,588 1,836,733 55,016 2,575,972 Shlomo Nachman 41,948,710 209,253 56,374 2,575,972 Karen N. Prange 40,301,694 1,857,627 55,016 2,575,972 Deborah H. Telman 40,249,839 1,909,510 54,988 2,575,972 Sven A. Wehrwein 40,080,389 2,078,609 55,339 2,575,972 Robert S. White 40,893,534 1,265,449 55,354 2,575,972 Maggie Yuen 41,565,558 593,708 55,071 2,575,972
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
AtriCure, Inc. shareholders approved Election of Shlomo Nachman as director at the 2024-05-14 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2024-05-14
Exact text from the filing
Each nominee for director was duty elected to serve one-year terms expiring at the 2025 Annual Meeting of Stockholders and until their successors have been duly elected and qualified. Director Nominees For Against Abstain Broker Non-Votes Michael H. Carrel 41,522,276 637,966 54,095 2,575,972 Regina E. Groves 41,564,382 594,967 54,988 2,575,972 B. Kristine Johnson 40,322,588 1,836,733 55,016 2,575,972 Shlomo Nachman 41,948,710 209,253 56,374 2,575,972 Karen N. Prange 40,301,694 1,857,627 55,016 2,575,972 Deborah H. Telman 40,249,839 1,909,510 54,988 2,575,972 Sven A. Wehrwein 40,080,389 2,078,609 55,339 2,575,972 Robert S. White 40,893,534 1,265,449 55,354 2,575,972 Maggie Yuen 41,565,558 593,708 55,071 2,575,972
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
AtriCure, Inc. shareholders approved Election of Maggie Yuen as director at the 2024-05-14 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2024-05-14
Exact text from the filing
Each nominee for director was duty elected to serve one-year terms expiring at the 2025 Annual Meeting of Stockholders and until their successors have been duly elected and qualified. Director Nominees For Against Abstain Broker Non-Votes Michael H. Carrel 41,522,276 637,966 54,095 2,575,972 Regina E. Groves 41,564,382 594,967 54,988 2,575,972 B. Kristine Johnson 40,322,588 1,836,733 55,016 2,575,972 Shlomo Nachman 41,948,710 209,253 56,374 2,575,972 Karen N. Prange 40,301,694 1,857,627 55,016 2,575,972 Deborah H. Telman 40,249,839 1,909,510 54,988 2,575,972 Sven A. Wehrwein 40,080,389 2,078,609 55,339 2,575,972 Robert S. White 40,893,534 1,265,449 55,354 2,575,972 Maggie Yuen 41,565,558 593,708 55,071 2,575,972
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
AtriCure, Inc. shareholders approved Election of B. Kristine Johnson as director at the 2024-05-14 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2024-05-14
Exact text from the filing
Each nominee for director was duty elected to serve one-year terms expiring at the 2025 Annual Meeting of Stockholders and until their successors have been duly elected and qualified. Director Nominees For Against Abstain Broker Non-Votes Michael H. Carrel 41,522,276 637,966 54,095 2,575,972 Regina E. Groves 41,564,382 594,967 54,988 2,575,972 B. Kristine Johnson 40,322,588 1,836,733 55,016 2,575,972 Shlomo Nachman 41,948,710 209,253 56,374 2,575,972 Karen N. Prange 40,301,694 1,857,627 55,016 2,575,972 Deborah H. Telman 40,249,839 1,909,510 54,988 2,575,972 Sven A. Wehrwein 40,080,389 2,078,609 55,339 2,575,972 Robert S. White 40,893,534 1,265,449 55,354 2,575,972 Maggie Yuen 41,565,558 593,708 55,071 2,575,972
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
AtriCure, Inc. shareholders approved Election of Sven A. Wehrwein as director at the 2024-05-14 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2024-05-14
Exact text from the filing
Each nominee for director was duty elected to serve one-year terms expiring at the 2025 Annual Meeting of Stockholders and until their successors have been duly elected and qualified. Director Nominees For Against Abstain Broker Non-Votes Michael H. Carrel 41,522,276 637,966 54,095 2,575,972 Regina E. Groves 41,564,382 594,967 54,988 2,575,972 B. Kristine Johnson 40,322,588 1,836,733 55,016 2,575,972 Shlomo Nachman 41,948,710 209,253 56,374 2,575,972 Karen N. Prange 40,301,694 1,857,627 55,016 2,575,972 Deborah H. Telman 40,249,839 1,909,510 54,988 2,575,972 Sven A. Wehrwein 40,080,389 2,078,609 55,339 2,575,972 Robert S. White 40,893,534 1,265,449 55,354 2,575,972 Maggie Yuen 41,565,558 593,708 55,071 2,575,972
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
AtriCure, Inc. shareholders approved Election of Karen N. Prange as director at the 2024-05-14 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2024-05-14
Exact text from the filing
Each nominee for director was duty elected to serve one-year terms expiring at the 2025 Annual Meeting of Stockholders and until their successors have been duly elected and qualified. Director Nominees For Against Abstain Broker Non-Votes Michael H. Carrel 41,522,276 637,966 54,095 2,575,972 Regina E. Groves 41,564,382 594,967 54,988 2,575,972 B. Kristine Johnson 40,322,588 1,836,733 55,016 2,575,972 Shlomo Nachman 41,948,710 209,253 56,374 2,575,972 Karen N. Prange 40,301,694 1,857,627 55,016 2,575,972 Deborah H. Telman 40,249,839 1,909,510 54,988 2,575,972 Sven A. Wehrwein 40,080,389 2,078,609 55,339 2,575,972 Robert S. White 40,893,534 1,265,449 55,354 2,575,972 Maggie Yuen 41,565,558 593,708 55,071 2,575,972
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
AtriCure, Inc. shareholders approved Election of Robert S. White as director at the 2024-05-14 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2024-05-14
Exact text from the filing
Each nominee for director was duty elected to serve one-year terms expiring at the 2025 Annual Meeting of Stockholders and until their successors have been duly elected and qualified. Director Nominees For Against Abstain Broker Non-Votes Michael H. Carrel 41,522,276 637,966 54,095 2,575,972 Regina E. Groves 41,564,382 594,967 54,988 2,575,972 B. Kristine Johnson 40,322,588 1,836,733 55,016 2,575,972 Shlomo Nachman 41,948,710 209,253 56,374 2,575,972 Karen N. Prange 40,301,694 1,857,627 55,016 2,575,972 Deborah H. Telman 40,249,839 1,909,510 54,988 2,575,972 Sven A. Wehrwein 40,080,389 2,078,609 55,339 2,575,972 Robert S. White 40,893,534 1,265,449 55,354 2,575,972 Maggie Yuen 41,565,558 593,708 55,071 2,575,972
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
AtriCure, Inc. shareholders approved Advisory vote on the compensation of the Company’s named executive officers as disclosed in the proxy statement at the 2024-05-14 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2024-05-14
Exact text from the filing
3. The stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the proxy statement. For: 35,640,238 Against: 6,475,860 Abstain: 98,239 Broker Non-Votes: 2,575,972
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
AtriCure, Inc. shareholders approved Election of Deborah H. Telman as director at the 2024-05-14 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2024-05-14
Exact text from the filing
Each nominee for director was duty elected to serve one-year terms expiring at the 2025 Annual Meeting of Stockholders and until their successors have been duly elected and qualified. Director Nominees For Against Abstain Broker Non-Votes Michael H. Carrel 41,522,276 637,966 54,095 2,575,972 Regina E. Groves 41,564,382 594,967 54,988 2,575,972 B. Kristine Johnson 40,322,588 1,836,733 55,016 2,575,972 Shlomo Nachman 41,948,710 209,253 56,374 2,575,972 Karen N. Prange 40,301,694 1,857,627 55,016 2,575,972 Deborah H. Telman 40,249,839 1,909,510 54,988 2,575,972 Sven A. Wehrwein 40,080,389 2,078,609 55,339 2,575,972 Robert S. White 40,893,534 1,265,449 55,354 2,575,972 Maggie Yuen 41,565,558 593,708 55,071 2,575,972
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
AtriCure, Inc. shareholders approved Election of Michael H. Carrel as director at the 2024-05-14 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2024-05-14
Exact text from the filing
Each nominee for director was duty elected to serve one-year terms expiring at the 2025 Annual Meeting of Stockholders and until their successors have been duly elected and qualified. Director Nominees For Against Abstain Broker Non-Votes Michael H. Carrel 41,522,276 637,966 54,095 2,575,972 Regina E. Groves 41,564,382 594,967 54,988 2,575,972 B. Kristine Johnson 40,322,588 1,836,733 55,016 2,575,972 Shlomo Nachman 41,948,710 209,253 56,374 2,575,972 Karen N. Prange 40,301,694 1,857,627 55,016 2,575,972 Deborah H. Telman 40,249,839 1,909,510 54,988 2,575,972 Sven A. Wehrwein 40,080,389 2,078,609 55,339 2,575,972 Robert S. White 40,893,534 1,265,449 55,354 2,575,972 Maggie Yuen 41,565,558 593,708 55,071 2,575,972
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
AtriCure, Inc. shareholders approved Approval of an amendment to the AtriCure, Inc. 2023 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 1,800,000 at the 2024-05-14 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2024-05-14
Exact text from the filing
4. The stockholders approved the amendment to the AtriCure, Inc. 2023 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 1,800,000. For: 40,884,921 Against: 1,252,515 Abstain: 76,901 Broker Non-Votes: 2,575,972
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.